EMA’s envisaged risk-based and human-centric approach to regulate AI
Written By
Bird & Bird’s international life sciences and healthcare team is at the forefront of the legal developments with regard to AI and the life sciences sector. This article is part of our new series, which will highlight different legal angles to consider when implementing AI in the life sciences and healthcare industry.
Latest insights
More Insights
Denmark: Supreme Court judgement regarding salary during suspension in connection with the summary dismissal of a municipal employee
Sep 13 2024
A spotlight on Australia Privacy Reform: A long awaited first step – First tranche privacy reforms introduced to Parliament
Sep 12 2024
NIS2 is about to become a reality in Denmark: What should your organisation be aware of?
Sep 12 2024